Alkermes Plc (ALKS) News, Price and Chart

Thu June 3rd, 2021

- 22:38
  Press ReleasesAlkermes to Take Part in the Goldman Sachs Annual Global Healthcare ConferencePR Newswire

Tue June 1st, 2021

- 13:35
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  IPOAlkermes Shares Move Higher On FDA Approval Of Schizophrenia, Bipolar MedBenzinga

Fri May 28th, 2021

- 20:00
  Press ReleasesAlkermes to Host Webcast With Expert Oncologist Panel to Discuss Data on Nemvaleukin Alfa Presented at 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPR Newswire

Fri May 7th, 2021

- 20:11
  AnalysisWhy Shares of Alkermes Rose 18% Last MonthThe Motley Fool

Mon May 3rd, 2021

- 11:00
  Press ReleasesAlkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness MonthPR Newswire

Thu April 29th, 2021

- 21:30
  EarningsAnalysisAlkermes PLC (ALKS) Q1 2021 Earnings Call TranscriptThe Motley Fool

Wed April 28th, 2021

Tue April 20th, 2021

- 20:01
  Press ReleasesAlkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the Schizophrenia International Research SocietyPR Newswire

Thu April 8th, 2021

- 18:56
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisMerck & Co. Is Flatlined But Watch For Its RevivalSeeking Alpha

Wed April 7th, 2021

- 11:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesAlkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin Alfa in Combination With KEYTRUDA® in Patients With Platinum-Resistant Ovarian CancerPR Newswire

Sun February 28th, 2021

- 12:38
  AnalysisTop Stocks To Buy On The Sell-OffSeeking Alpha

Wed February 24th, 2021

- 15:15
  Press Releases$6.3 Billion Growth in Addiction Therapeutics Market During 2021-2025 | Featuring Alkermes Plc and Emergent BioSolutions Inc. among others | TechnavioPR Newswire

Thu February 18th, 2021

- 21:00
  Press ReleasesAlkermes to Take Part in SVB Leerink 10th Annual Global Healthcare ConferencePR Newswire

Thu February 11th, 2021

Thu February 4th, 2021

- 19:15
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisTop Heavily-Shorted Stocks You Can Buy NowSeeking Alpha

Wed January 6th, 2021

- 21:00
  Press ReleasesAlkermes to Present at the 39th Annual J.P. Morgan Healthcare ConferencePR Newswire

Fri January 1st, 2021

- 17:52
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisThe Top Stocks To Buy In The New YearSeeking Alpha

Fri December 11th, 2020

- 13:53
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisThe Best Big-Cap Stocks To Buy On A PullbackSeeking Alpha

Thu December 10th, 2020

- 19:58
  AnalysisHere's Why Alkermes Shares Jumped Higher TodayThe Motley Fool

Fri December 4th, 2020

- 18:55
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisThe Grinch Could Derail The Santa Claus Rally This YearSeeking Alpha

Tue November 17th, 2020

- 12:00
  Press ReleasesGuideAlkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records ReviewPR Newswire

Sun November 1st, 2020

- 12:57
  EarningsAnalysisAlkermes plc (ALKS) CEO Richard Pops on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha

Fri October 30th, 2020

- 22:00
  EarningsAnalysisAlkermes PLC (ALKS) Q3 2020 Earnings Call TranscriptThe Motley Fool
- 14:04
  RumorsAlkermes (ALKS) Highlighted as Activist TargetStreetInsider

Thu October 29th, 2020

- 14:04
  EarningsAnalysisAlkermes plc 2020 Q3 - Results - Earnings Call PresentationSeeking Alpha
- 11:00
  Press ReleasesAlkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial ExpectationsPR Newswire

Thu October 22nd, 2020

- 20:00
  Press ReleasesAlkermes to Host Conference Call to Discuss Third Quarter 2020 Financial ResultsPR Newswire

Wed October 14th, 2020

- 03:00
  AnalysisBristol-Myers Squibb Reports Positive Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Fri October 9th, 2020

- 11:05
  Press ReleasesTrading in Alkermes Ordinary Shares Halted TodayPR Newswire

Wed October 7th, 2020

- 14:14
  Press ReleasesAlkermes Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on ALKS 3831PR Newswire

Mon October 5th, 2020

- 13:51
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  90
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  RumorsAlkermes (ALKS) on Watch as Board Nomination Window Opens - AnalystStreetInsider

Mon September 28th, 2020

- 21:07
  AnalysisAlkermes: Schizophrenia Drug Producer Taking Market Share, 5.5% 3-Month UpsideSeeking Alpha

Tue September 22nd, 2020

- 10:52
  AnalysisAlkermes Plc (ALKS) Investor Presentation - SlideshowSeeking Alpha

Fri September 18th, 2020

- 10:30
  Press ReleasesAlkermes Presents New Clinical Data on ALKS 4230 in Mini Oral Presentation at 2020 European Society for Medical Oncology (ESMO) Virtual CongressPR Newswire

Mon September 14th, 2020

- 11:00
  Press ReleasesAlkermes Presents New Psychiatry Data at Psych Congress 2020 Virtual ExperiencePR Newswire